Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. It operates through three segments: Hong Kong, Mainland China, and Overseas. The company offers Chinese medical consultation and treatment services. It also operates retail outlets in H… Read more
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) - Total Assets
Latest total assets as of June 2025: $4.53 Billion USD
Based on the latest financial reports, Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) holds total assets worth $4.53 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Beijing Tong Ren Tang Chinese Medicine Company Limited - Total Assets Trend (2015–2024)
This chart illustrates how Beijing Tong Ren Tang Chinese Medicine Company Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Beijing Tong Ren Tang Chinese Medicine Company Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Beijing Tong Ren Tang Chinese Medicine Company Limited's total assets of $4.53 Billion consist of 87.0% current assets and 13.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 38.9% |
| Accounts Receivable | $67.69 Million | 11.5% |
| Inventory | $204.47 Million | 34.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.30 Million | 0.4% |
| Goodwill | $6.36 Million | 1.1% |
Asset Composition Trend (2015–2024)
This chart illustrates how Beijing Tong Ren Tang Chinese Medicine Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Beijing Tong Ren Tang Chinese Medicine Company Limited's current assets represent 87.0% of total assets in 2024, an increase from 82.0% in 2015.
- Cash Position: Cash and equivalents constituted 38.9% of total assets in 2024, up from 37.5% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 5.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 34.9% of total assets.
Beijing Tong Ren Tang Chinese Medicine Company Limited Competitors by Total Assets
Key competitors of Beijing Tong Ren Tang Chinese Medicine Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Beijing Tong Ren Tang Chinese Medicine Company Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Beijing Tong Ren Tang Chinese Medicine Company Limited generates 2.75x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Beijing Tong Ren Tang Chinese Medicine Company Limited generates $ 10.97 in net profit.
Beijing Tong Ren Tang Chinese Medicine Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 18.17 | 16.79 | 13.54 |
| Quick Ratio | 11.43 | -39.79 | 11.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.71 Billion | $ 447.11 Million | $ 2.72 Billion |
Beijing Tong Ren Tang Chinese Medicine Company Limited - Advanced Valuation Insights
This section examines the relationship between Beijing Tong Ren Tang Chinese Medicine Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.10 |
| Latest Market Cap to Assets Ratio | 0.26 |
| Asset Growth Rate (YoY) | 3.3% |
| Total Assets | $586.72 Million |
| Market Capitalization | $153.70 Million USD |
Valuation Analysis
Below Book Valuation: The market values Beijing Tong Ren Tang Chinese Medicine Company Limited's assets below their book value (0.26 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Beijing Tong Ren Tang Chinese Medicine Company Limited's assets grew by 3.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Beijing Tong Ren Tang Chinese Medicine Company Limited (2015–2024)
The table below shows the annual total assets of Beijing Tong Ren Tang Chinese Medicine Company Limited from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $586.72 Million | +3.34% |
| 2023-12-31 | $567.74 Million | +4.47% |
| 2022-12-31 | $543.45 Million | +9.83% |
| 2021-12-31 | $494.82 Million | +11.65% |
| 2020-12-31 | $443.18 Million | +10.03% |
| 2019-12-31 | $402.77 Million | -0.56% |
| 2018-12-31 | $405.03 Million | +14.69% |
| 2017-12-31 | $353.15 Million | +16.27% |
| 2016-12-31 | $303.72 Million | +16.13% |
| 2015-12-31 | $261.54 Million | -- |